LABP Insider Trading Activity and SEC Form 4 Filings
LABP insider trading summary
No open-market insider purchases or sales of Landos Biopharma, Inc. (LABP) have been reported on SEC Form 4 in the past 12 months.
Latest LABP insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Feb 28, 2023 | Josep Bassaganya-Riera | 10% Owner | Sell | $0 (786,299 @ $0.00) |
| Feb 28, 2023 | Josep Bassaganya-Riera | 10% Owner | Sell | $0 (496,527 @ $0.00) |
| Feb 28, 2023 | Josep Bassaganya-Riera | 10% Owner | Sell | $0 (3,470,736 @ $0.00) |
| Feb 28, 2023 | Josep Bassaganya-Riera | 10% Owner | Sell | $0 (467,306 @ $0.00) |
| Feb 28, 2023 | Josep Bassaganya-Riera | 10% Owner | Sell | $0 (500,000 @ $0.00) |
| Sep 23, 2022 | Roderick Wong | 10% Owner | Sell | $207K (300,000 @ $0.69) |
| Sep 23, 2022 | Rtw Investments, LP | 10% Owner | Sell | $207K (300,000 @ $0.69) |
| Dec 20, 2021 | Josep Bassaganya-Riera | 10% Owner | Sell | $158K (33,194 @ $4.75) |
| Dec 17, 2021 | Josep Bassaganya-Riera | 10% Owner | Sell | $174K (36,000 @ $4.84) |
| Dec 16, 2021 | Josep Bassaganya-Riera | 10% Owner | Sell | $124K (24,301 @ $5.11) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.